E91G (p.Glu91Gly) variant of IRS1 (Insulin receptor substrate 1)
E91G (p.Glu91Gly) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
E91G (p.Glu91Gly) variant details
- p.Glu91Gly
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.